Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
11 May 2017
Notification of Major Interest in Mediclinic International plc shares
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: |
Mediclinic International plc |
2 Reason for the notification (please tick the appropriate box or boxes): |
An acquisition or disposal of voting rights |
x |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
An event changing the breakdown of voting rights |
|
Other (please specify): |
|
|
3. Full name of person(s) subject to the
notification obligation: |
Coronation Asset Management (Pty) Ltd |
4. Full name of shareholder(s)
(if different from 3.): |
N/A |
5. Date of the transaction and date on
which the threshold is crossed or
reached: |
11 May 2017 |
6. Date on which issuer notified: |
11 May 2017 |
7. Threshold(s) that is/are crossed or
reached: |
5% |
8. Notified details: |
|
A: Voting rights attached to shares |
|
Class/type of
shares
if possible using
the ISIN CODE
|
Situation previous
to the triggering
transaction |
Resulting situation after the triggering transaction |
|
Number
of
Shares |
Number
of
Voting
Rights |
Number
of shares |
Number of voting
rights |
% of voting rights |
|
Direct |
Direct |
Indirect |
Direct |
Indirect |
|
GB00B8HX8Z88 |
37 306 089 |
37 306 089 |
36 139 844 |
36 139 844 |
|
4.90% |
|
|
|
|
|
|
B: Qualifying Financial Instruments |
|
Resulting situation after the triggering transaction |
|
Type of financial
instrument |
Expiration
date |
Exercise/
Conversion Period |
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted. |
% of voting
rights |
|
|
|
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
|
Resulting situation after the triggering transaction |
|
Type of financial
instrument |
Exercise price |
Expiration date |
Exercise/
Conversion period |
Number of voting rights instrument refers to |
% of voting rights |
|
|
|
|
|
|
Nominal |
Delta |
|
|
|
|
|
|
Total (A+B+C) |
|
Number of voting rights |
Percentage of voting rights |
|
36 139 844 |
4.90% |
|
|
|
|
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: |
|
|
|
|
|
Proxy Voting: |
|
10. Name of the proxy holder: |
Coronation Asset Management (Pty) Ltd |
|
11. Number of voting rights proxy holder will cease
to hold: |
|
|
12. Date on which proxy holder will cease to hold
voting rights: |
|
|
|
|
13. Additional information:
|
|
|
14. Contact name: |
Jamie Rowland |
|
15. Contact telephone number: |
+27 21 680 2000 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South
Africa and on the NSX in Namibia.
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600